Suppr超能文献

对比剂用量与肾小球滤过率的比值可预测经导管主动脉瓣植入术后的急性肾损伤和死亡率。

The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and mortality after transcatheter aortic valve implantation.

作者信息

Giannini Francesco, Latib Azeem, Jabbour Richard J, Slavich Massimo, Benincasa Susanna, Chieffo Alaide, Montorfano Matteo, Stella Stefano, Buzzatti Nicola, Alfieri Ottavio, Colombo Antonio

机构信息

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy.

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy.

出版信息

Cardiovasc Revasc Med. 2017 Jul-Aug;18(5):349-355. doi: 10.1016/j.carrev.2017.02.011. Epub 2017 Feb 20.

Abstract

OBJECTIVE

The aim of this study was to assess the impact of the ratio of volume of contrast medium to the glomerular filtration rate (V/GFR) on acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) and its impact on long-term mortality.

METHODS

We retrospectively calculated V/GFR in 397 patients undergoing TAVI. AKI was defined as VARC-modified Risk, Injury, Failure, Loss and End-stage (RIFLE) kidney disease score≥2.

RESULTS

The incidence of AKI was 17.9%. The mean V/GFR ratio was 3.0±2.7 in patients without AKI and 7.8±8.8 in patients with AKI (p<0.001). The receiver-operator characteristic curve analysis showed fair discrimination between patients with and without AKI (C-statistic 0.85) at a V/GFR ratio of 3.2. Multivariable regression analysis indicated that V/GFR>3.2 was an independent predictor of both AKI (OR 3.4, 95% CI 1.0-6.1, p<0.001) and long-term mortality (OR 3.3, 95% CI 2.0-5.2, p<0.001).

CONCLUSIONS

A V/GFR > 3.2 was found to be correlated with a higher incidence of AKI and mortality after TAVI. Therefore, this ratio could potentially be used to calculate the maximum volume of contrast medium that can be administered without significantly increasing the risk of AKI and mortality. Further larger studies are needed to validate these findings.

摘要

目的

本研究旨在评估造影剂体积与肾小球滤过率之比(V/GFR)对经导管主动脉瓣植入术(TAVI)后急性肾损伤(AKI)的影响及其对长期死亡率的影响。

方法

我们回顾性计算了397例行TAVI患者的V/GFR。AKI定义为VARC改良的风险、损伤、衰竭、丧失和终末期(RIFLE)肾病评分≥2。

结果

AKI的发生率为17.9%。无AKI患者的平均V/GFR比值为3.0±2.7,有AKI患者为7.8±8.8(p<0.001)。受试者工作特征曲线分析显示,在V/GFR比值为3.2时,有和无AKI患者之间有较好的区分度(C统计量0.85)。多变量回归分析表明,V/GFR>3.2是AKI(OR 3.4,95%CI 1.0-6.1,p<0.001)和长期死亡率(OR 3.3,95%CI 2.0-5.2,p<0.001)的独立预测因素。

结论

发现V/GFR>3.2与TAVI后较高的AKI发生率和死亡率相关。因此,该比值可能可用于计算在不显著增加AKI和死亡率风险的情况下可给予的最大造影剂体积。需要进一步的大型研究来验证这些发现。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验